Back

Zoonotic tuberculosis in India: looking beyond Mycobacterium bovis

Duffy, S. C.; Srinivasan, S.; Schilling, M. A.; Stuber, T.; Danchuk, S. N.; Michael, J. S.; Venkatesan, M.; Bansal, N.; Maan, S.; Jindal, N.; Chaudhary, D.; Dandapat, P.; Katani, R.; Chothe, S.; Veerasami, M.; Robbe-Austerman, S.; Juleff, N.; Kapur, V.; Behr, M. A.

2019-11-20 microbiology
10.1101/847715 bioRxiv
Show abstract

BackgroundZoonotic tuberculosis (zTB) is the transmission of Mycobacterium tuberculosis complex (MTBC) subspecies from animals to humans. zTB is generally quantified by determining the proportion of human isolates that are Mycobacterium bovis. Although India has the worlds largest number of human TB cases and the largest cattle population, where bovine TB is endemic, the burden of zTB is unknown. MethodsTo obtain estimates of zTB in India, a PCR-based approach was applied to sub-speciate positive MGIT(R) cultures from 940 patients (548 pulmonary, 392 extrapulmonary disease) at a large referral hospital in India. Twenty-five isolates of interest were subject to whole genome sequencing (WGS) and compared with 715 publicly available MTBC sequences from South Asia. FindingsA conclusive identification was obtained for 939 samples; wildtype M. bovis was not identified (95% CI: 0 - 0.4%). There were 912 M. tuberculosis sensu stricto (97.0%, 95% CI: 95.7 - 98.0), 7 M. orygis (95% CI: 0.3 - 1.5%); 5 M. bovis BCG, and 15 non-tuberculous mycobacteria. WGS analysis of 715 MTBC sequences again identified no M. bovis (95% CI: 0 - 0.4%). Human and cattle MTBC isolates were interspersed within the M. orgyis and M. tuberculosis sensu stricto lineages. InterpretationM. bovis prevalence in humans is an inadequate proxy of zTB in India. The recovery of M. orygis from humans, together with the finding of M. tuberculosis in cattle, underscores the need for One Health investigations to assess the burden of zTB in countries with endemic bovine TB. FundingBill & Melinda Gates Foundation, Canadian Institutes for Health Research

Matching journals

The top 4 journals account for 50% of the predicted probability mass.

1
Journal of Clinical Microbiology
130 papers in training set
Top 0.1%
18.2%
2
Microbial Genomics
225 papers in training set
Top 0.3%
11.7%
3
Tuberculosis
11 papers in training set
Top 0.1%
10.9%
4
Microbiology Spectrum
469 papers in training set
Top 1.0%
9.5%
50% of probability mass above
5
The Journal of Infectious Diseases
202 papers in training set
Top 0.9%
4.0%
6
Emerging Infectious Diseases
105 papers in training set
Top 0.4%
3.2%
7
PLOS ONE
5266 papers in training set
Top 39%
3.1%
8
PLOS Neglected Tropical Diseases
466 papers in training set
Top 3%
2.7%
9
eLife
5828 papers in training set
Top 39%
2.6%
10
Journal of Infection
78 papers in training set
Top 0.4%
2.6%
11
mBio
833 papers in training set
Top 6%
2.4%
12
International Journal of Infectious Diseases
129 papers in training set
Top 1.0%
2.4%
13
Frontiers in Cellular and Infection Microbiology
109 papers in training set
Top 1%
2.4%
14
Antimicrobial Agents and Chemotherapy
187 papers in training set
Top 1.0%
2.4%
15
Nature Communications
5641 papers in training set
Top 45%
1.7%
16
Scientific Reports
3612 papers in training set
Top 71%
1.0%
17
PLOS Pathogens
820 papers in training set
Top 9%
1.0%
18
Access Microbiology
25 papers in training set
Top 0.6%
1.0%
19
mSphere
302 papers in training set
Top 7%
0.8%
20
Frontiers in Microbiology
427 papers in training set
Top 8%
0.8%
21
Frontiers in Veterinary Science
32 papers in training set
Top 0.8%
0.6%
22
Microbiology Resource Announcements
25 papers in training set
Top 0.6%
0.6%